Our Global Community

Connecting young liver scholars across six continents

CYSL Publications

Highlighting the latest research from our community members across leading journals

Steering Committee

Guiding the strategic direction and scientific vision of CYSL

Ying Shang

Karolinska Institutet, Stockholm

Steatotic liver disease, MASLD, clinical epidemiology

Zhujun Cao

Ruijin Hospital, Shanghai

Decompensated cirrhosis, ACLF and infectious diseases

Xiaolong Qi

Zhongda Hospital, Nanjing

Novel Tech for Cirrhosis and Portal Hypertension

Wenhao Li

Royal London Hospital, London

Innate immune signaling, T cell immune landscape

Yee Hui Yeo

Cleveland Clinic, Cleveland

Alcohol-associated liver disease, AI in Hepatology

Kaina Chen

Singapore General Hospital, Singapore

Liver cancer, cirrhosis, portal hypertension, GI endoscopy

The Steering Committee provides high-level strategic guidance and scientific oversight for CYSL. Comprising distinguished leaders in hepatology from across the globe, the committee ensures the program maintains the highest standards of academic excellence and impact.

Members

A global network of liver disease researchers and clinicians

Zhao Huang

Tongji Hospital

Refractory HCC & Precision Treatment

Haiyuan Shen

Anhui Medical University

Metabolic Liver Disease & Gut-liver Axis

Tao Zhou

Naval Medical University

Single-cell Spatiotemporal Evolution

Meng Xu

Nanfang Hospital

Liver Fibrosis & MAFLD

Hui Li

Zhongshan Hospital

Immunotherapy Resistance in HCC

Chunyan Liu

Nanjing University

Liver Regeneration & Tissue Engineering